MRPL42 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.14479553509273E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.31850000309564E-08 |
Normal-vs-Stage2 |
1.646610E-04 |
Normal-vs-Stage3 |
1.82780000024252E-07 |
Normal-vs-Stage4 |
3.01592084639424E-12 |
Stage1-vs-Stage2 |
8.417800E-01 |
Stage1-vs-Stage3 |
5.093800E-01 |
Stage1-vs-Stage4 |
1.237640E-01 |
Stage2-vs-Stage3 |
5.187600E-01 |
Stage2-vs-Stage4 |
2.066800E-01 |
Stage3-vs-Stage4 |
6.036800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.70550026826299E-10 |
Normal-vs-AfricanAmerican |
3.93896026906759E-12 |
Normal-vs-Asian |
1.37820000001287E-06 |
Caucasian-vs-AfricanAmerican |
3.256400E-02 |
Caucasian-vs-Asian |
5.459900E-02 |
AfricanAmerican-vs-Asian |
7.573200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.0738527802614E-13 |
Normal-vs-Female |
4.01960000000479E-05 |
Male-vs-Female |
1.368030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.37570000338749E-08 |
Normal-vs-Age(41-60Yrs) |
2.34570000090528E-08 |
Normal-vs-Age(61-80Yrs) |
8.08849986988491E-10 |
Normal-vs-Age(81-100Yrs) |
2.304799999997E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.500430E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.075800E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.225400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.614000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.350600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.525800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.593100E-04 |
Normal-vs-Grade 2 |
4.43530000000525E-05 |
Normal-vs-Grade 3 |
1.65334412827178E-12 |
Normal-vs-Grade 4 |
1.79878334449768E-12 |
Grade 1-vs-Grade 2 |
4.390000E-01 |
Grade 1-vs-Grade 3 |
5.855800E-01 |
Grade 1-vs-Grade 4 |
2.245800E-01 |
Grade 2-vs-Grade 3 |
4.045500E-02 |
Grade 2-vs-Grade 4 |
5.602400E-03 |
Grade 3-vs-Grade 4 |
1.957560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.161600E-04 |
Normal-vs-ccB subtype |
8.26105850393333E-12 |
ccA subtype-vs-ccB subtype |
1.004390E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.07489994682908E-09 |
Normal-vs-N1 |
2.795400E-01 |
N0-vs-N1 |
6.799000E-01 |
|
|